Drug Class: Bacterial vaccines
0.5 mL, IM or subcutaneously, once
Comments:
2 years and older at increased risk of pneumococcal disease:
0.5 mL, IM or subcutaneously, once
Data not available
Data not available
Safety and efficacy have not been established in patients younger than 2 years.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov
Consult WARNINGS section for additional precautions.
Data not available
Administration advice: